Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection-Reference-Cited by-同舟云学术

Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection

Published:2016 Issue:3 Volume:35 Page:123-128
ISSN:2186-3342
Container-title:Bioscience of Microbiota, Food and Health
language:en
Short-container-title:

Author:

OO Khin May¹,LWIN Aye Aye¹,KYAW Yi Yi¹,TUN Win Maw¹,FUKADA Kazutake²,GOSHIMA Akiko²,SHIMADA Takashi²³,OKADA Shigeru⁴

Affiliation:

1. Department of Medical Research (Lower Myanmar), No. 5 Ziwaka Road, 11191 Yangon, Republic of the Union of Myanmar

2. Central Research Laboratories, Nichinichi Pharmaceutical Corporation Ltd., Mie 518-1417, Japan

3. Department of Gastrointestinal Immunology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

4. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-0811, Japan

Publisher

BMFH Press

Subject

Gastroenterology,Applied Microbiology and Biotechnology,Immunology,Microbiology,Food Science

Link

https://www.jstage.jst.go.jp/article/bmfh/35/3/35_2015-024/_pdf

Reference25 articles.

1. 1. Kyi PK, Win KM. 1995. Viral hepatitis in Myanmar. DMR Bull 9: 1–31.

2. 2. Kyi PK, Win KM, Aye M, Htwe YY, Oo KM, Aung T, Oo SS. 1998. Prevalence of hepatitis B and C infection in hepatocellular carcinoma cases in Myanmar. Myanmar Health Sci Res J 10: 1–5.

3. 3. Win KM. 2000. Clinical aspect of hepatitis C infection. Proceeding of Seminar on Control of Hepatitis C in Myanmar: 6–10.

4. 4. Gupta S, Kanodia AK. 2002. Biological response modifiers in cancer therapy. Natl Med J India 15: 202–207.

5. 5. Huber CH, Wölfel T. 2004. Immunotherapy of cancer: from vision to standard clinical practice. J Cancer Res Clin Oncol 130: 367–374.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating gut microbiota by paraprobiotics: Mechanisms, advantages, and challenges;Food Bioscience;2024-08

2. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases;Seminars in Immunology;2024-02

3. Heat-treated and/or lysozyme-treated <i>Enterococcus faecalis</i> (FK-23) improves the progression of renal disease in a unilateral ischemia-reperfusion injury rat model;Journal of Clinical Biochemistry and Nutrition;2024

4. Overview of anti-viral effects of probiotics via immune cells in pre-, mid- and post-SARS-CoV2 era;Frontiers in Immunology;2023-12-05

5. Immunomodulation and enhancing the immunity: Unveiling the potential of designer diets;Future Foods;2023-12